Stay updated on Dociparstat Sodium with Standard Induction in AML Clinical Trial

Sign up to get notified when there's something new on the Dociparstat Sodium with Standard Induction in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dociparstat Sodium with Standard Induction in AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2025-06-12T15:26:12.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.6%
    Check dated 2025-06-05T08:13:59.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T05:45:42.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.6%
    Check dated 2025-04-30T13:52:03.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2025-04-23T08:19:49.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding a detailed study on the combination of dociparstat with standard induction therapy for acute myeloid leukemia, including specific study design, endpoints, and eligibility criteria. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    10%
    Check dated 2025-04-16T01:43:44.000Z thumbnail image

Stay in the know with updates to Dociparstat Sodium with Standard Induction in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dociparstat Sodium with Standard Induction in AML Clinical Trial page.